Mitral balloon valvuloplasty in pregnancy: Limiting radiation and procedure time by using transesophageal echocardiography

Canadian Journal of Cardiology

Volumn 13, Issue 9, 1997, Pages 843-845

  Poirier, Paul ^a   Champagne, Jean ^a   Alain, Pierre ^a   Martineau, André ^a   Marquis, Yves ^a   Dumesnil, Jean G ^a   Boudreault, Jean R ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Mitral stenosis; Pregnancy; Pulsed fluoroscopy; Transesophageal echocardiography

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DYSPNEA; FEMALE; FLUOROSCOPY; HUMAN; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PAROXYSMAL DYSPNEA; PREGNANCY; RADIATION EXPOSURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSLUMINAL VALVULOPLASTY;

ADULT; BALLOON DILATATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FLUOROSCOPY; HUMANS; MITRAL VALVE STENOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RADIATION PROTECTION; TIME FACTORS;

EID: 0030813710     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Gangbar EW, Watson KR, Howard RJ, Chisholm RJ. Mitral balloon valvuloplasty in pregnancy: advantages of unique balloon. Carher Cardiovasc Diagn 1992;25:313-6.
2. Kültürsay H, Türkoglu C, Akin M, Payzin S, Soydas C, Akill A. Mitral balloon valvuloplasty with transesophageal echocardiography without using fluoroscopy. Cather Cardiovasc Diagn 1992;27:317-21.
3. Presbitero P, Prever SB, Brusca A. Interventional cardiology in pregnancy. Eur Heart J 1996;17:182-8.
4. Safian RD, Berman AD, Sachs B, et al. Percutaneous balloon mitral valvuloplasty in a pregnant woman with mitral stenosis. Cathet Cardiovasc Diagn 1988;15:103-8.
5. Lung B, Cormier B, Elias J, et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994;73:398-400.
6. Stern SH, Rosenstein M, Renaud L, Zanki M. Handbook of selected tissue doses for fluoroscopic and cineangiographic examination of the coronary arteries [Publication 95-8289]. Rockville: US Department of Health and Human Services, Food and Drug Administration , 1995.